Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2021-03-01 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 28/2/2021. The content focuses on share capital changes and confirmations related to securities issued during the month. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements to the exchange, consistent with regulatory compliance disclosures rather than a financial report or announcement of a report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-03-01 English
EXPECTED DECREASE IN LOSS
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to the Listing Rules and Inside Information Provisions of the Hong Kong Stock Exchange. It provides a preliminary assessment of the company's unaudited consolidated management accounts for the year ended 31 December 2020, indicating an expected decrease in loss. The announcement explicitly states that the information is based on unaudited preliminary data and that the final audited annual results will be announced later. The document is relatively short (4244 characters) and serves as an update or alert to shareholders and investors rather than a full financial report. It does not contain detailed financial statements or substantive financial data but rather a summary of expected financial performance. Therefore, it fits the profile of a Regulatory Filing (RNS) as a general regulatory announcement and inside information disclosure rather than an Annual Report (10-K) or Earnings Release (ER).
2021-02-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/1/2021, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and confirmations related to securities issued during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory monthly return about share capital movements, which fits the category of Share Issue/Capital Change announcements rather than a full financial report or other categories. The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement of a report. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2021-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2020, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and confirmations related to securities issued during the month. This type of document is a regulatory filing that reports monthly changes in share capital and securities movements, typically required by stock exchanges for listed companies. It is not an annual or quarterly financial report, nor an earnings release, nor a management or board announcement. It is also not a proxy, voting result, or remuneration report. The document is a periodic regulatory disclosure about share capital movements, fitting the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-01-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/11/2020, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on changes in share capital and securities issued during the month, with confirmations regarding compliance with listing rules. This type of document is a regulatory filing reporting monthly share capital movements rather than a full financial report, earnings release, or management discussion. It is not an announcement of a report publication but a substantive regulatory disclosure. Therefore, it fits best under the category 'Regulatory Filings (RNS)' as a general regulatory announcement that does not fit more specific categories like share issue announcements or director dealings, since it covers a broad range of share capital movements in a monthly return format.
2020-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 31/10/2020. The content is focused on share capital changes and confirmations related to securities issued during the month. This type of document is a regulatory filing that reports monthly changes in share capital and securities movements, typically required by stock exchanges for listed companies. It is not an annual or quarterly financial report, nor is it an earnings release, management report, or any other specific report type. It is a regulatory compliance filing reporting share capital movements. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is substantial and contains detailed data, but it is not a financial report itself, rather a regulatory disclosure.
2020-11-02 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.